Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex.Climacteric. 2022 08; 25(4):323-326.C
Abstract
Postmenopausal vulvovaginal pain and atrophy require appropriate and sensitive outcomes that correlate with the genital discomfort, symptoms and expected changes. In some studies, hormone and laser treatments do not detect benefits due to the fact that appropriate measuring tools were not used. While some studies have demonstrated placebo effects for both therapeutic approaches, others support that sham-intervention could be a therapeutic by creating a conditioning reflex. However, obtained results are directly related with the quality of outcomes: you get what you measure. It is imperative to follow the Core Outcomes in Menopause global initiative.
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
35352627
Citation
Pérez-López, F R., and S R. Varikasuvu. "Vulvovaginal Atrophy Management With a Laser: the Placebo Effect or the Conditioning Pavlov Reflex." Climacteric : the Journal of the International Menopause Society, vol. 25, no. 4, 2022, pp. 323-326.
Pérez-López FR, Varikasuvu SR. Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex. Climacteric. 2022;25(4):323-326.
Pérez-López, F. R., & Varikasuvu, S. R. (2022). Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex. Climacteric : the Journal of the International Menopause Society, 25(4), 323-326. https://doi.org/10.1080/13697137.2022.2050207
Pérez-López FR, Varikasuvu SR. Vulvovaginal Atrophy Management With a Laser: the Placebo Effect or the Conditioning Pavlov Reflex. Climacteric. 2022;25(4):323-326. PubMed PMID: 35352627.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex.
AU - Pérez-López,F R,
AU - Varikasuvu,S R,
Y1 - 2022/03/30/
PY - 2022/3/31/pubmed
PY - 2022/7/12/medline
PY - 2022/3/30/entrez
KW - Carbon dioxide laser
KW - dyspareunia
KW - estrogen
KW - female sexual function
KW - genitourinary syndrome of menopause
KW - meta-analysis
KW - vulvovaginal atrophy
SP - 323
EP - 326
JF - Climacteric : the journal of the International Menopause Society
JO - Climacteric
VL - 25
IS - 4
N2 - Postmenopausal vulvovaginal pain and atrophy require appropriate and sensitive outcomes that correlate with the genital discomfort, symptoms and expected changes. In some studies, hormone and laser treatments do not detect benefits due to the fact that appropriate measuring tools were not used. While some studies have demonstrated placebo effects for both therapeutic approaches, others support that sham-intervention could be a therapeutic by creating a conditioning reflex. However, obtained results are directly related with the quality of outcomes: you get what you measure. It is imperative to follow the Core Outcomes in Menopause global initiative.
SN - 1473-0804
UR - https://www.unboundmedicine.com/medline/citation/35352627/Vulvovaginal_atrophy_management_with_a_laser:_the_placebo_effect_or_the_conditioning_Pavlov_reflex.
DB - PRIME
DP - Unbound Medicine
ER -